SIRPA and atrial fibrillation: For the first time, we tested the expression of a cell surface marker CD172α (SIRPA) on AF-MSCs induced to cardiomyogenic differentiation and detected up to 40–50% of positive AF-MSCs (induced using RA and AngII + RA).